# Leucine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/leucine

- Industry: Healthcare IT
- Headquarters: New York, US
- Website: www.leucine.io
- Total disclosed funding: $7M
- Latest round: Series A (Oct 16, 2023)
- Investors on record: 4

## About

Based in New York, US, and founded in 2019 by CEO Vivek Gera and and CPO Mushtaq Singh, Leucine, Inc. operates as a developer of an artificial intelligence-based platform to manage compliance and audit for pharmaceutical manufacturers. In October 2023, Leucine, Inc. raised USD 7 million in Series A funding led by new investor Ecolab, with participation from returning investors Axilor Ventures, Pravega Ventures, and TechStars.

The company offers an integrated dashboard platform to generate insights, transfer compliance risks, and improve productivity for pharmaceutical manufacturers. The company offers a variety of product solutions such as batch planning, material tracking, batch execution, product changeover, quality metrics, investigations, cleaning validation, QC planning, batch release, sample testing, and many more. In addition, the firm provides a wide range of platforms for various roles including Leucine10x, GxP compliant process builder, analytics and reporting, ontology and process interlocks, immutable logbooks, and integrations. As of 2023, Leucine, Inc.'s client base includes Lupin, Mylan, Stelis, Cipla, Tenshi, Piramal, etc.

The company plans to use the funding from October 2023 for tracking the development of Leucine's Compliance Cloud platform and its artificial intelligence (AI)-driven tools tailored for the pharmaceutical manufacturing sector.

## Funding rounds

- Series A, Oct 16, 2023, $7M — Ecolab, Techstars, Axilor Ventures, Pravega Ventures

## Investors

- Ecolab — Series A
- Techstars (https://capitalatlas.ai/funds/techstars) — Series A
- Axilor Ventures (https://capitalatlas.ai/funds/axilor-ventures) — Series A
- Pravega Ventures (https://capitalatlas.ai/funds/pravega-ventures) — Series A